Skip to content

A Chemical peeling safety and efficacy test

An Exploratory study of safety and efficacy of the new chemical peeling

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs031230071
Enrollment
25
Registered
2023-05-15
Start date
2023-05-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy adult

Interventions

chemical peeling

Sponsors

Nogita Toshitatsu
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1)Those who have expressed their willingness to participate in the study, understood the explanation, and agreed in writing to participate in the study 2)Healthy Japanese women between the ages of 20 and 70 who wish to improve solar lentigines, freckle spots, chloasma, so-called dullness, and who do not meet the exclusion criteria, regardless of the presence or absence of diseases such as pigment spots 3)Those who can fill in documents such as consent forms, questionnaires, usage diaries, etc. 4)Those who can come to the facility on the designated observation day

Exclusion criteria

Exclusion criteria: 1)Subjects who are likely to be exposed to sunlight during the test period (daytime sports, etc.) 2)Subjects who are strongly aware of sensitive skin 3)Those who have experienced allergic symptoms due to cosmetics etc 4)Subjects with skin symptoms such as atopic dermatitis, seborrheic eczema, and vitiligo, and those with a history of them 5)Subjects with coagulation disorder, immune disorder, facial herpes, severe acne, eczema, etc. 6)Those with severe hay fever 7)Subjects with a history of serious liver disorder, renal disorder, or myocardial infarction 8)Those who are pregnant or during the study period, those who may become pregnant, and those who are breastfeeding 9)Subjects who received facial, high-frequency treatment, injection treatment, etc. within 3 months from the start of the study 10)Those who participated in other clinical trials, research, etc. within 6 months of the start of the trial 11)Those who plan to participate in other clinical trials during the trial period 12)Subjects with skin symptoms not suitable for chemical peeling on the face 13)In addition, those who have symptoms that should be excluded by the attending physician or responsible physician

Design outcomes

Primary

MeasureTime frame
Safety assessment

Secondary

MeasureTime frame
Instrumental skin measurement/Stratum Corneum examination/ visual observation/ photograph evaluation /skein tone color scale/Microscope observation/Satisfaction survey after using test product

Contacts

Public ContactMasahiro Kuramochi

Beauty and Health Research,Inc Medical Research Department

kuramochi@b-hr.jp+81-3-5354-7388

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026